157 related articles for article (PubMed ID: 22244657)
1. [Mitral regurgitation of unknown etiology in a 20-year-old patient].
Caro J; Inmaculada Navarro-Hidalgo M; Bonanad C; Real JT; Ascaso JF
Endocrinol Nutr; 2012 May; 59(5):333-5. PubMed ID: 22244657
[No Abstract] [Full Text] [Related]
2. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
Wittström E; Nordling M; Andréasson S
Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
[TBL] [Abstract][Full Text] [Related]
3. Case report: a synonymous VHL mutation (c.414A > G, p.Pro138Pro) causes pathogenic familial hemangioblastoma through dysregulated splicing.
Liu F; Calhoun B; Alam MS; Sun M; Wang X; Zhang C; Haldar K; Lu X
BMC Med Genet; 2020 Feb; 21(1):42. PubMed ID: 32106822
[TBL] [Abstract][Full Text] [Related]
4. von Hippel-Lindau syndrome.
Chou A; Toon C; Pickett J; Gill AJ
Front Horm Res; 2013; 41():30-49. PubMed ID: 23652669
[TBL] [Abstract][Full Text] [Related]
5. Pheochromocytoma and clear-cell renal carcinoma in a child with von Hippel-Lindau disease: a patient report.
Ferragut J; Caimari M; Rituerto B; Gómez-Rivas B; Herrera M; Alonso F
J Pediatr Endocrinol Metab; 1999; 12(4):579-82. PubMed ID: 10417977
[TBL] [Abstract][Full Text] [Related]
6. von Hippel-Lindau disease.
Couch V; Lindor NM; Karnes PS; Michels VV
Mayo Clin Proc; 2000 Mar; 75(3):265-72. PubMed ID: 10725953
[TBL] [Abstract][Full Text] [Related]
7. [Retinal capillary hemangioma and von Hippel-Lindau disease: diagnostic and therapeutic implications].
Salazar R; González-Castaño C; Rozas P; Castro J
Arch Soc Esp Oftalmol; 2011 Jul; 86(7):218-21. PubMed ID: 21798408
[TBL] [Abstract][Full Text] [Related]
8. [Von Hippel-Lindau disease].
Takahashi K; Iida K; Chihara K
Nihon Rinsho; 2006 Sep; Suppl 3():351-4. PubMed ID: 17022562
[No Abstract] [Full Text] [Related]
9. Genotype-phenotype correlations in VHL exon deletions.
McNeill A; Rattenberry E; Barber R; Killick P; MacDonald F; Maher ER
Am J Med Genet A; 2009 Oct; 149A(10):2147-51. PubMed ID: 19764026
[TBL] [Abstract][Full Text] [Related]
10. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
11. Pheochromocytoma in von Hippel-Lindau disease: clinical presentation and mutation analysis in a large, multigenerational kindred.
Atuk NO; Stolle C; Owen JA; Carpenter JT; Vance ML
J Clin Endocrinol Metab; 1998 Jan; 83(1):117-20. PubMed ID: 9435426
[TBL] [Abstract][Full Text] [Related]
12. [Von Hippel-Lindau disease: family study].
González Escobar AB; Morillo Sánchez MJ; García-Campos JM
Arch Soc Esp Oftalmol; 2012 Nov; 87(11):368-72. PubMed ID: 23058196
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma in a von Hippel-Lindau syndrome: when should phaeochromocytoma be anticipated?
Azarisman SM; Nor Azmi K
Singapore Med J; 2007 Aug; 48(8):779-82. PubMed ID: 17657389
[TBL] [Abstract][Full Text] [Related]
14. Hypertension in pregnancy: think laterally.
Carty D; Crichton L; Alakandy L; O'Dwyer P; Dominiczak A
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):220-1. PubMed ID: 20362384
[No Abstract] [Full Text] [Related]
15. Third International Meeting on von Hippel-Lindau disease.
Zbar B; Kaelin W; Maher E; Richard S
Cancer Res; 1999 May; 59(9):2251-3. PubMed ID: 10232616
[TBL] [Abstract][Full Text] [Related]
16. [Malignant pheochromocytoma combined with multiple renal cell carcinomas and a renal cyst. Indication for von Hippel-Lindau syndrome?].
Hofmockel G; Manseck A
Dtsch Med Wochenschr; 2000 Jun; 125(24):767-8. PubMed ID: 10902516
[No Abstract] [Full Text] [Related]
17. Multidisciplinar surgical treatment in a case of von Hippel-Lindau with CNS hemangioblastoma, bilateral adrenal pheochromocytoma and multiple bilateral renal cell carcinoma--a case report.
Baccari P; Colombo R; Spotti D; Giovannelli M; Corlatti M; Staudacher C
Contrib Nephrol; 2001; (136):281-3. PubMed ID: 11688394
[No Abstract] [Full Text] [Related]
18. Use of the tyrosine kinase inhibitor sunitinib in a patient with von Hippel-Lindau disease: targeting angiogenic factors in pheochromocytoma and other von Hippel-Lindau disease-related tumors.
Jimenez C; Cabanillas ME; Santarpia L; Jonasch E; Kyle KL; Lano EA; Matin SF; Nunez RF; Perrier ND; Phan A; Rich TA; Shah B; Williams MD; Waguespack SG
J Clin Endocrinol Metab; 2009 Feb; 94(2):386-91. PubMed ID: 19017755
[TBL] [Abstract][Full Text] [Related]
19. [Tumors outside of the central nervous system in Von Hippel-Lindau disease].
Veltman GA; Arntzenius AB; Oosterwijk JC; Lycklamaá Nijeholt AA; Roelfsema F
Ned Tijdschr Geneeskd; 1996 Apr; 140(15):823-6. PubMed ID: 8668275
[No Abstract] [Full Text] [Related]
20. Pediatric endocrine screening for von Hippel-Lindau disease: benefits and the challenge of compliance.
Prasad R; Johnston LB; Savage MO; Martin L; Perry LA; Storr HL
J Endocrinol Invest; 2011 Apr; 34(4):296-9. PubMed ID: 20585202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
